Palvella Therapeutics (NASDAQ:PVLA – Get Free Report) and Bionano Genomics (NASDAQ:BNGO – Get Free Report) are both small-cap medical companies, but which is the superior investment? Get Palvella Therapeutics alerts:Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Palvella Therapeutics $42.81 million 16.99 -$17.43 million ($12.10) -5.44 Bionano Genomics $30.78 million 0.26 -$112.02 million ($138.92) -0.01Volatility and RiskPalvella Therapeutics has higher revenue and earnings than Bionano Genomics. ProfitabilityThis table compares Palvella Therapeutics and Bionano Genomics’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Palvella Therapeutics N/A -62.30% -43.34% Bionano Genomics -271.02% -129.41% -72.25%Analyst RatingsThis is a breakdown of recent ratings and recommmendations for Palvella Therapeutics and Bionano Genomics, as provided by MarketBeat. Given Bionano Genomics’ higher possible upside, analysts clearly believe Bionano Genomics is more favorable than Palvella Therapeutics.